Literature DB >> 24522926

Ectromelia virus encodes a BTB/kelch protein, EVM150, that inhibits NF-κB signaling.

Qian Wang1, Kristin Burles, Brianne Couturier, Crystal M H Randall, Joanna Shisler, Michele Barry.   

Abstract

UNLABELLED: The NF-κB signaling pathway plays a critical role in inflammation and innate immunity. Consequently, many viruses have evolved strategies to inhibit NF-κB in order to facilitate replication and evasion of the host immune response. Recently, we determined that ectromelia virus, the causative agent of mousepox, contains a family of four BTB/kelch proteins that interact with cullin-3-based ubiquitin ligases. We demonstrate here that expression of EVM150, one of the four BTB/kelch proteins, inhibited NF-κB activation induced by tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β). Although EVM150 inhibited NF-κB p65 nuclear translocation, IκBα degradation was observed, indicating that EVM150 functioned downstream of IκBα degradation. Significantly, expression of the BTB-only domain of EVM150 blocked NF-κB activation, demonstrating that EVM150 functioned independently of the kelch domain and its role as an adapter for cullin-3-based ubiquitin ligases. Furthermore, cullin-3 knockdown by small interfering RNA demonstrated that cullin-3-based ubiquitin ligases are dispensable for TNF-α-induced NF-κB activation. Interestingly, nuclear translocation of IRF3 and STAT1 still occurred in the presence of EVM150, indicating that EVM150 prevented NF-κB nuclear translocation specifically. In addition to identifying EVM150 as an inhibitor of the NF-κB pathway, this study provides new insights into the role of BTB/kelch proteins during virus infection. IMPORTANCE: With the exception of virulence studies, little work has been done to determine the role of poxviral BTB/kelch proteins during infection. This study, for the first time, has identified a mechanism for the ectromelia virus BTB/kelch protein EVM150. Here, we show that EVM150 is a novel inhibitor of the cellular NF-κB pathway, an important component of the antiviral response. This study adds EVM150 to the growing list of NF-κB inhibitors in poxviruses and provides new insights into the role of BTB/kelch proteins during virus infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522926      PMCID: PMC3993801          DOI: 10.1128/JVI.02923-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Authors:  A Melnick; K F Ahmad; S Arai; A Polinger; H Ball; K L Borden; G W Carlile; G G Prive; J D Licht
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 3.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

4.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

Review 5.  Transcriptional regulation via the NF-kappaB signaling module.

Authors:  A Hoffmann; G Natoli; G Ghosh
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

6.  The POZ domain: a conserved protein-protein interaction motif.

Authors:  V J Bardwell; R Treisman
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

7.  Evidence for actin cytoskeleton-dependent and -independent pathways for RelA/p65 nuclear translocation in endothelial cells.

Authors:  Fabeha Fazal; Mohd Minhajuddin; Kaiser M Bijli; James L McGrath; Arshad Rahman
Journal:  J Biol Chem       Date:  2006-12-08       Impact factor: 5.157

Review 8.  Ubiquitin in NF-kappaB signaling.

Authors:  Yu-Hsin Chiu; Meng Zhao; Zhijian J Chen
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

9.  Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection.

Authors:  Daniel Rubio; Ren-Huan Xu; Sanda Remakus; Tracy E Krouse; Mary Ellen Truckenmiller; Roshan J Thapa; Siddharth Balachandran; Antonio Alcamí; Christopher C Norbury; Luis J Sigal
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

10.  Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B.

Authors:  Shannon L Taylor; Natalia Frias-Staheli; Adolfo García-Sastre; Connie S Schmaljohn
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

View more
  13 in total

1.  Out of the Reservoir: Phenotypic and Genotypic Characterization of a Novel Cowpox Virus Isolated from a Common Vole.

Authors:  Donata Hoffmann; Annika Franke; Maria Jenckel; Aistė Tamošiūnaitė; Julia Schluckebier; Harald Granzow; Bernd Hoffmann; Stefan Fischer; Rainer G Ulrich; Dirk Höper; Katja Goller; Nikolaus Osterrieder; Martin Beer
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

Review 3.  Recent advances on viral manipulation of NF-κB signaling pathway.

Authors:  Jun Zhao; Shanping He; Arlet Minassian; Junhua Li; Pinghui Feng
Journal:  Curr Opin Virol       Date:  2015-09-15       Impact factor: 7.090

4.  Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.

Authors:  Lindy M Lutz; Chandler R Pace; Michelle M Arnold
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

5.  Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65).

Authors:  Haiwei Du; Peiqi Yin; Xiaojie Yang; Leiliang Zhang; Qi Jin; Guofeng Zhu
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

Review 6.  Cullin E3 ligases and their rewiring by viral factors.

Authors:  Cathal Mahon; Nevan J Krogan; Charles S Craik; Elah Pick
Journal:  Biomolecules       Date:  2014-10-13

7.  EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence.

Authors:  Nicholas van Buuren; Kristin Burles; Jill Schriewer; Ninad Mehta; Scott Parker; R Mark Buller; Michele Barry
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

Review 8.  Poxviral ankyrin proteins.

Authors:  Michael H Herbert; Christopher J Squire; Andrew A Mercer
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

9.  A parapoxviral virion protein inhibits NF-κB signaling early in infection.

Authors:  Sushil Khatiwada; Gustavo Delhon; Ponnuraj Nagendraprabhu; Sabal Chaulagain; Shuhong Luo; Diego G Diel; Eduardo F Flores; Daniel L Rock
Journal:  PLoS Pathog       Date:  2017-08-07       Impact factor: 6.823

10.  Functional paralysis of GM-CSF-derived bone marrow cells productively infected with ectromelia virus.

Authors:  Lidia Szulc-Dąbrowska; Justyna Struzik; Agnieszka Ostrowska; Maciej Guzera; Felix N Toka; Magdalena Bossowska-Nowicka; Małgorzata M Gieryńska; Anna Winnicka; Zuzanna Nowak; Marek G Niemiałtowski
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.